Advanced Search
Korean J Pediatr 1994 August;37(8) :1035-1047.
Effect of Glucocorticoid-Induced Hyperglycemia on Preventing Hypoxic-Ischemic Brain Damage by Dexamethasone in Neonatal Rat
Kook In Park (Park KI)1, Tae Seung Kim (Kim TS)2, Min Soo Park (Park MS)1, Moon Sung Park (Park MS)1, Ran Namgung (Namgung R)1, Chul Lee (Lee C)1, Dong Gwan Han (Han DG)1
1Department of Pediatrics, Yonsei University, College of Medicine, Seoul, Korea
2Department of Anatomic Pathology, Yonsei University, College of Medicine, Seoul, Korea
Copyright © 1994 by The Korean Pediatric Society
Purpose : We evaluated the protective effect of dexamethasone (DX) administration on brain damage produced in a perinatal model of cerebral hypoxia-ischemia in the rat. Since hyperglycemia has been shown to reduce hypoxic-ischemic brain injury (HI) in immature rat, we investigated the role of glucocorticoid-induced hyperglycemia in the neuroprotective mechanism of DX. Methods : Hypoxic-ischemic brain injury in 7-day-old rats was induced by right common carotid artery occlusion and 2 hours of 8% oxygen. Pups received 3 doses of DX (0.5 mg/kg/d intraperitoneally) 48 hours, 24 hours and immediately before HI (Dx1)(n=12), a single dose of DX 24 hours (DX2)(n=16), 3 hours (DX3)(n=10) or immediately before HI(DX4)(n=14), a single dose of DX immediately after HI(DX5)(n=9), 3 doses of DX immediately, 24 hours and 48 hours after HI (DX6)(n=14) and a single dose of DX 24 hours before HI with insulin (0.5 U/kg, subcutaneously, 1.5 hours before (HI)(IN) (n=8). Control pups (n=15) received a single dose of normal saline 24 hours before HI. Blood glucose was estimated before hypoxia, 1 hour and 2 hours after hypoxia using glucometer in DX 1~4. IN and control rats. Pups were kolled at 14 days of age for determination of mortality during HI, gross ceregral infarction and right cerebral hemisphere atrophy. We measured the diameter of ech cerebral hemisphere and cortical thickness from a coronal section at the dorsal hippocampus level, and expressed the % atrophy from the change in the right vs left hemisphere diameter. Results : The mortaility that occurred during and after HI was similar in all groups. The incidence of gross cerebral infarction was 0.0%, 0.0%, 75.0%, 83.3%, 87.5%, and 90.0% in DX 1~6, respectively, 0.0% in IN, and 100.0% in control group. There was significant difference (p<0.001) in the incidence of gross cerebral infarction of DX1, Dx2, In vs control group. The mean % atrophy was 5.42.2, 4.91.8, 21.78.1, 29.75.0, 37.45.5, 33.49.3 in DX 1~6, respectively, 1.51.1 in IN, and 29.13.4 (meanSEM) in control group. There was a significant difference in % atrophy of DX1, DX2, IN vs control group. Before hypoxia, there was no significant difference in blood glucose between saline, all DX, and DX with insulin treated groups. But after hypoxia, pups in DX1 and DX2 were more hyperglycemic compared to DX 3~4, IN, or saline treated groups. Conclusion : Dexamethasone administration in the neonatal period protects the brain during the subsequent periods of hypoxia-ischemia in rats and glucocorticoid-induced hyperglycemia does not explain the neuroprotective effects dexamethasone.
Keywords: Dexamethasone | Glucocorticoid-induced hyperglycemia | Hypoxic-ischemic brain injury | Newborn rat
PDF Links  PDF Links
Full text via DOI  Full text via DOI
Download Citation  Download Citation
Supplementary Material  Supplementary Material
Possible Neuroprotective Role of Exogenous Growth Hormone on Hypoxic-Ischemic Brain Injury in Neonatal Rats  2004 November;47(11)
The Effect of Postnatal Dexamethasone Treatment on Hypoxic-Ischemic Brain Injury in Neonatal Rats  2003 October;46(10)
Effect of Vitamin E on Cerebral Hypoxia-Ischemia in Neonatal Rats  2001 July;44(7)
Register for e-submission
Register here to access the e-submission system of Korean J Pediatr for authors and reviewers.
Manuscript Submission
To submit a manuscript, please visit the Korean J Pediatr e-submission management system at, read the Instructions for Authors, and log into the Korean J Pediatr e-submission system. For assistance with manuscript submission, please contact:
Free archive
Anyone may access any past or current articles without logging in.
Korean Pediatric Society Office
#1606, Seocho World Officetel, 19 Seoun-ro, Seocho-gu, Seoul 137-070, Korea
TEL : +82-2-3473-7305    FAX : +82-2-3473-7307   E-mail:
BrowseCurrent IssueFor Authors and ReviewersAbout
Copyright© The Korean Pediatric Society. All right reserved.